Q: would like your thoughts on RJF as a value + growth story. It has been hit hard with the US financial melt down but is not a bank. Has a decent growth profile? , dividend and trades at a reasonable (cheap?) multiple.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
AbbVie Inc. (ABBV $230.50)
-
Abbott Laboratories (ABT $132.57)
-
Danaher Corporation (DHR $202.46)
-
Johnson & Johnson (JNJ $190.72)
-
Eli Lilly and Company (LLY $833.49)
-
Merck & Company Inc. (MRK $85.99)
-
Thermo Fisher Scientific Inc (TMO $524.80)
-
GE HealthCare Technologies Inc. (GEHC $71.01)
Q: In the US healthcare space, I am looking for a value priced name with meaningful upside total return potential (3 to 5 years) ideally with some current yield. Am thinking ABBV but not sure if I should be looking at pure play pharmaceutical, equipment mfg or..? CVS already owned
Thoughts please on above or others, and thanks
Thoughts please on above or others, and thanks
Q: What is your opinion on this stock/
-
Harvest Healthcare Leaders Income ETF (HHL $7.34)
-
Harvest Tech Achievers Growth & Income ETF (HTA $19.01)
Q: Thoughts on these etfs in a non registered account
How would the distributions be taxed
How would the distributions be taxed
Q: Pfe had tumbled from 52 week H of $54.93 to recent 52 week low of $36.17.Very positive reaction to the tune of + 4.87%(at $38.56) to today's favourable peer reviewed study of oral drug for weight loss. In light of the above,is it timely to buy some? Txs for U usual great services & views.Happy Victoria Day
Q: Is VNQ a good investment in a stagflation environment, or does its current issue of office and retail REIT exposure going to counteract that situation ?
Are rising interest rates the only other reason for its underperformance recently?
Is it possible to come up with a metric that compares how expensive / inexpensive it is today as an investment relative to it's past ?
Thanks.
Are rising interest rates the only other reason for its underperformance recently?
Is it possible to come up with a metric that compares how expensive / inexpensive it is today as an investment relative to it's past ?
Thanks.
Q: Please give your assessment of this ETF - AIQ. It appears to hold stocks that have been driving the S&P500 higher this year so do you see any more upside? How much growth do you see for AI in the short and long term? For a growth theme would you put new money into this for 2-5 years? Thanks in advance and please deduct credits as you see fit.
Q: Which one would you like to add to today for a long term holding? thank you.
Q: I have taken a position in this company and see that it has been added to the Russell 2000 and am wondering if I should add on weakness before June23rd.
Thanks for your answer
Thanks for your answer
Q: This company has had quite a run up recently and wonder if you have any comments on it and if it is worth buying in at this point.
Thanks,
Lesley
Thanks,
Lesley
-
Abbott Laboratories (ABT $132.57)
-
Medtronic plc. (MDT $95.45)
-
Tandem Diabetes Care Inc. (TNDM $14.00)
-
DexCom Inc. (DXCM $65.12)
Q: What are your current thoughts on this company (TNDM) and do you think it has bottomed? Thanks as usual.
Q: Peter; Someone step on Crox this am? Thanks.rod
Q: Hey guys, my dad is 78, what would be your top 3 Vanguard’s value ETF recommendations ?
thank you !
thank you !
Q: Pfizer Inc is planning to raise $31 billion through its largest debt offering to finance its proposed acquisition of Seagen Inc, the drugmaker said late on Tuesday.
Could I get your opinion? Lot of money.
Could I get your opinion? Lot of money.
Q: I would like to increase my health care sector and am considering adding to ABBV or start a new position in PFE. The valuation of PFE looks good in comparison. For a long term hold in a LIF, which one would you select? Thanks
Gary
Gary
-
HubSpot Inc. (HUBS $439.66)
-
Datadog Inc. (DDOG $158.74)
-
Palantir Technologies Inc. (PLTR $175.44)
-
Snowflake Inc. (SNOW $242.17)
Q: Which of the above appeals the most for a five year high-risk AI play?
Q: Hi,
Your analysis of Stone's latest results ?
Thanks
Your analysis of Stone's latest results ?
Thanks
Q: Is it too late to get into NVDA? There is talk about AI being a new indusrtial revolution and NVDA is the significant chip player. That being said, the stock has already had a significant run upwards. Am analyst today suggests that NVDA could rise five fold in the next ten year. Is this one to buy, even with a higher stock price than preferred?
Q: NVDA shares have been increasing in value recently by leaps and bounds. I am happy to be up >100%. (A shout out here to 5i's excellent advice regarding this stock.) What is causing this meteoric rise...and, more importantly, is it sustainable? Wondering here if I should let this winner run (it's 6% of my total portfolio now)...or start to divest.
Q: Which would be your choice to initiate a new position. $ISRG or $SYK?